Jim Burns re­unites with Gen­zyme col­league at En­so­ma; Lil­ly ex­ec to re­tire af­ter 27 years

Jim Burns was look­ing for his next post af­ter his lat­est ven­ture in biotech, a gene ther­a­py start­up known as Lo­can­abio, shut down “

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.